Astrazeneca Plc Stock Pattern Recognition Two Crows

AZN Stock  USD 184.32  4.09  2.17%   
AstraZeneca PLC pattern recognition tool provides the execution environment for running the Two Crows recognition and other technical functions against AstraZeneca PLC. AstraZeneca PLC value trend is the prevailing direction of the price over some defined period of time. The concept of trend is an important idea in technical analysis, including the analysis of pattern recognition indicators. As with most other technical indicators, the Two Crows recognition function is designed to identify and follow existing trends. AstraZeneca PLC momentum indicators are usually used to generate trading rules based on assumptions that AstraZeneca PLC trends in prices tend to continue for long periods.

Recognition
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was twelve with a total number of output elements of fourty-nine. The function did not return any valid pattern recognition events for the selected time horizon. Two Crows is a 3-day pattern that warns about a possible future trend reversal for AstraZeneca PLC.

AstraZeneca PLC Technical Analysis Modules

Most technical analysis of AstraZeneca PLC help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for AstraZeneca from various momentum indicators to cycle indicators. When you analyze AstraZeneca charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About AstraZeneca PLC Predictive Technical Analysis

Predictive technical analysis modules help investors to analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of AstraZeneca PLC. We use our internally-developed statistical techniques to arrive at the intrinsic value of AstraZeneca PLC based on widely used predictive technical indicators. In general, we focus on analyzing AstraZeneca Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build AstraZeneca PLC's daily price indicators and compare them against related drivers, such as pattern recognition and various other types of predictive indicators. Using this methodology combined with a more conventional technical analysis and fundamental analysis, we attempt to find the most accurate representation of AstraZeneca PLC's intrinsic value. In addition to deriving basic predictive indicators for AstraZeneca PLC, we also check how macroeconomic factors affect AstraZeneca PLC price patterns. Please read more on our technical analysis page or use our predictive modules below to complement your research.
 2024 2025 2026 (projected)
Dividend Yield0.02280.02050.0221
Price To Sales Ratio3.834.414.19
Hype
Prediction
LowEstimatedHigh
155.53184.32213.11
Details
Intrinsic
Valuation
LowRealHigh
105.80134.59202.75
Details
Earnings
Estimates (0)
LowProjected EPSHigh
1.131.151.18
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as AstraZeneca PLC. Your research has to be compared to or analyzed against AstraZeneca PLC's peers to derive any actionable benefits. When done correctly, AstraZeneca PLC's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in AstraZeneca PLC.

Become your own money manager

As an individual investor, you need to find a reliable way to track all your investment portfolios' performance accurately. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing you full analytical transparency into your positions, our tools can tell you how much better you can do without increasing your risk or reducing expected return.

Did you try this?

Run Portfolio Holdings Now

   

Portfolio Holdings

Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
All  Next Launch Module

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
Macroaxis Index Idea
Macroaxis Index
Invested over 90 shares
SRI Sustainable Growth Idea
SRI Sustainable Growth
Invested over 90 shares
ESG Investing Idea
ESG Investing
Sold few shares
Millennials Best Idea
Millennials Best
Invested over 90 shares
When determining whether AstraZeneca PLC offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of AstraZeneca PLC's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Astrazeneca Plc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Astrazeneca Plc Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in AstraZeneca PLC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
To learn how to invest in AstraZeneca Stock, please use our How to Invest in AstraZeneca PLC guide.
You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Will Drug Manufacturers - General sector continue expanding? Could AstraZeneca diversify its offerings? Factors like these will boost the valuation of AstraZeneca PLC. If investors know AstraZeneca will grow in the future, the company's valuation will be higher. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every AstraZeneca PLC data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth
0.78
Dividend Share
3.13
Earnings Share
3.01
Revenue Per Share
3.1126
Quarterly Revenue Growth
0.12
The market value of AstraZeneca PLC is measured differently than its book value, which is the value of AstraZeneca that is recorded on the company's balance sheet. Investors also form their own opinion of AstraZeneca PLC's value that differs from its market value or its book value, called intrinsic value, which is AstraZeneca PLC's true underlying value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Because AstraZeneca PLC's market value can be influenced by many factors that don't directly affect AstraZeneca PLC's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Understanding that AstraZeneca PLC's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether AstraZeneca PLC represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Meanwhile, AstraZeneca PLC's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.